Halladay Benjamin 4
4 · Esperion Therapeutics, Inc. · Filed Dec 18, 2024
Insider Transaction Report
Form 4
Halladay Benjamin
Chief Financial Officer
Transactions
- Sale
Common Stock
2024-12-17$2.42/sh−3,245$7,866→ 240,691 total
Footnotes (1)
- [F1]Shares were sold to satisfy tax obligation on vested shares of restricted stock units.